0001209191-23-024878.txt : 20230419 0001209191-23-024878.hdr.sgml : 20230419 20230419173525 ACCESSION NUMBER: 0001209191-23-024878 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230417 FILED AS OF DATE: 20230419 DATE AS OF CHANGE: 20230419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shaker Benjamin CENTRAL INDEX KEY: 0001855843 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40332 FILM NUMBER: 23830888 MAIL ADDRESS: STREET 1: C/O AGILON HEALTH, INC. STREET 2: 6210 E HWY 290, SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: agilon health, inc. CENTRAL INDEX KEY: 0001831097 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 371915147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6210 E HWY 290 STREET 2: SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 BUSINESS PHONE: 562-256-3800 MAIL ADDRESS: STREET 1: 6210 E HWY 290 STREET 2: SUITE 450 CITY: AUSTIN STATE: TX ZIP: 78723 FORMER COMPANY: FORMER CONFORMED NAME: Agilon Health Topco, Inc. DATE OF NAME CHANGE: 20201103 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-04-17 0 0001831097 agilon health, inc. AGL 0001855843 Shaker Benjamin C/O AGILON HEALTH, INC. 6210 E HWY 290, SUITE 450 AUSTIN TX 78723 0 1 0 0 Chief Markets Officer 1 Common Stock 2023-04-17 4 M 0 1851 1.00 A 81394 D Common Stock 2023-04-17 4 M 0 23149 3.00 A 104543 D Common Stock 2023-04-17 4 S 0 23600 27.6966 D 80943 D Common Stock 2023-04-17 4 S 0 1400 28.5407 D 79543 D Common Stock 2023-04-18 4 M 0 25000 3.00 A 104543 D Common Stock 2023-04-18 4 S 0 25000 28.0452 D 79543 D Options (Right to buy) 1.00 2023-04-17 4 M 0 1851 0.00 D 2027-04-27 Common Stock 1851 0 D Options (Right to buy) 3.00 2023-04-17 4 M 0 23149 0.00 D 2027-04-27 Common Stock 23149 76851 D Options (Right to buy) 3.00 2023-04-18 4 M 0 25000 0.00 D 2027-04-27 Common Stock 25000 51851 D Includes restricted stock units. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan effective 15 Sept. 2022. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.42 to $28.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $28.46 to $28.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $27.64 to $28.255, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. These options were granted on April 27, 2017, and became fully vested as of January 12, 2021. These options were granted on April 27, 2017, and became fully vested as of September 14, 2021. /s/ Steve Meetre, as Attorney-in-Fact 2023-04-19